Inviga Healthcare Fund, the private equity platform founded by cancer care chain HCG founder Dr. B. S. Ajaikumar, has acquired a 21% stake in Forus Health Pvt. Ltd., an Indian med-tech company working on AI-driven ophthalmic diagnostics. The investment marks Inviga’s second major bet after backing vaccine innovator Mynvax in 2024.

The financial details of the investment were not disclosed.

Forus Health, best known for its 3nethra series of eye screening devices, has screened over 22 million patients across 75 countries. Its AI-powered platform for ocular diagnostics and oculomics has reached more than 5 million patients globally, enabling last-mile access to comprehensive eye care. The company’s latest innovation, the 3nethra specto — a smartphone-controlled wearable digital refractor —

See Full Page